4.7 Article

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy

Related references

Note: Only part of the references are listed.
Article Cell Biology

Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2

Yunqing Gu et al.

Summary: The study identified ASGR1 and KREMEN1 as alternative functional receptors for SARS-CoV-2, in addition to ACE2, which together play essential roles in virus entry. The combination of these receptors affects virus susceptibility across different cell types and displays a stronger correlation with virus susceptibility when expressed together. In human lung organoids, a cocktail of antibodies targeting these three receptors provides the most significant blockage of SARS-CoV-2 infection when compared to individual antibodies.

CELL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2

Jiamnin Liu et al.

Summary: This study reveals that SARS-CoV-2 can enter cells not only by binding to ACE2 through its spike protein, but also by binding to integrin alpha 5 beta 1. The activation of integrin plays a critical role in facilitating the internalization of SARS-CoV-2 into non-ACE2 cells. This alternative pathway for cell entry may contribute to the further infection and progression of COVID-19.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Pathology

Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences

Randall J. Olsen et al.

Summary: This study reports the SARS-CoV-2 genome sequences of 12,476 patients diagnosed in the Houston Methodist health care system from January 1 to May 31, 2021. It highlights the rapid increase of the B.1.1.7 variant, causing a significant proportion of new cases in late May in Houston, TX, as well as the emergence of the B.1.617 variants in the metroplex.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Microbiology

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Zhuoming Liu et al.

Summary: The study found that antibodies targeting the SARS-CoV-2 spike protein have escape mutations, different monoclonal antibodies have unique resistance profiles, some mutants are resistant to multiple antibodies while some variants can escape neutralization by convalescent sera. Comparing antibody-mediated mutations with circulating SARS-CoV-2 sequences revealed substitutions that may weaken neutralizing immune responses in some individuals, warranting further investigation.

CELL HOST & MICROBE (2021)

Article Virology

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

Helena Winstone et al.

Summary: The presence of a polybasic cleavage site in the spike protein of SARS-CoV-2 allows the virus to enter cells in a pH-independent manner, mitigating against IFITM-mediated restriction and promoting replication and transmission. Targeted depletion of IFITM2 expression alleviates potent inhibition of SARS-CoV-2 replication by type I IFNs. Therapeutic strategies targeting furin-mediated cleavage of the spike protein may reduce viral replication through the activity of type I IFNs.

JOURNAL OF VIROLOGY (2021)

Article Microbiology

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication

Santseharay Ramirez et al.

Summary: Efforts to combat the COVID-19 pandemic include repurposing existing antiviral drugs and screening their efficacy in different cell lines. In this study, serial passages of SARS-CoV-2 in human liver and lung cancer cells led to the selection of a more infective variant with spike protein mutations. The adapted virus showed less dependence on ACE2 and increased susceptibility to interferon, demonstrating the potential for antiviral drug screening efficacy across different cell lines.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Microbiology

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Thomas P. Peacock et al.

Summary: Efficient transmission of SARS-CoV-2 among infected ferrets is dependent on a functional furin cleavage site in the spike protein. The virus has a selective advantage in lung cells and primary human airway epithelial cells due to a polybasic insertion, but replication may be impaired in certain cell lines.

NATURE MICROBIOLOGY (2021)

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Cell Biology

Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

Maritza Puray-Chavez et al.

Summary: This study identifies human H522 lung adenocarcinoma cells as permissive to SARS-CoV-2 infection and reveals the importance of the E484D S variant for infection. Vaccinated individuals' sera block the alternative entry mechanism, whereas convalescent sera are less effective.

CELL REPORTS (2021)

Article Medicine, General & Internal

Multiorgan and Renal Tropism of SARS-CoV-2

Victor G. Puelles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Thomas Mandel Clausen et al.